Investing Ideas
/
Swedish Pharmaceuticals & Biotech High Return On Equity, Low Debt

Swedish Pharmaceuticals & Biotech High Return On Equity, Low Debt

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Stocks with a return on equity of over 30% and a debt to equity ratio below 1.

1 companies

Cantargia

Market Cap: SEK 1.0b

A biotechnology company, develops pharmaceuticals for treatment of cancer, inflammatory, and autoimmune diseases.

CANTA

SEK 4.14

-9.8%

141.1%